Market Overview:
The global nasal polyps drugs market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of nasal polyps, rising awareness about available treatment options, and technological advancements in the field of nasal polyps drugs. The global nasal polyps drugs market is segmented on the basis of type into corticosteroids, antibiotics, leukotriene inhibitors, and others. The corticosteroids segment is expected to account for the largest share of the global market in 2018. This segment is also projected to grow at a CAGR of 5.9% during the forecast period from 2018 to 2030 due to its high efficacy and safety profile as compared to other types of drugs available for treating nasal polyps.
Product Definition:
Nasal polyps are sac-like growths that protrude from the lining of your nose. They're usually small, but they can grow large enough to block your nasal passages. This can make it difficult to breathe and may cause other problems, such as snoring or sleep apnea.
Corticosteroids:
Corticosteroids are the group of drugs whose action is to reduce inflammation by suppressing the release of inflammatory cytokines by immune cells. Corticosteroid nasal spray is used for treatment and prevention of nasal congestion due to allergies, colds, and flu.
Antibiotics:
Antibiotics are drugs used to treat bacterial infections. The most common types of bacterial infections are urinary tract, pneumonia, skin and soft tissue, bloodstream infection, ear infection and middle ear infection. Antibiotics can be administered in two ways; as a prescription drug or as an over the counter (OTC) drug.
Application Insights:
The others segment held the largest share of the global nasal polyps drugs market in 2017. This is due to a high prevalence of asthma and other respiratory disorders, which drive the demand for various treatment options, including anti-inflammatory corticosteroids and leukotriene inhibitors. According to estimates published by Global Asthma Report Card in 2018, around 54 million people suffer from asthma worldwide; however, only 36% of them are receiving proper treatment.
According to data published by Global Burden of Disease Study in 2017 regarding deaths caused by asthma every year globally was around 509 thousand; this number is expected to increase with time as more people are suffering from this chronic disease.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, advanced healthcare infrastructure and high adoption rate for technologically advanced treatment are some of the factors responsible for its large share. Moreover, rising incidence of nasal polyps is also one factor contributing to its largest share. According to a study conducted by National Institute of Health (NIH), in U.S., about 1 out of 5 people aged 65 years and above had suffered from nasal polyps which increases their risk up to 90%.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to increasing prevalence rates coupled with growing awareness regarding various treatment options available for these disorders along with economic development in this region will drive growth over next eight years – 2030 – 29).
Growth Factors:
- Increasing prevalence of nasal polyps
- Growing awareness about the treatment options for nasal polyps
- Rising demand for minimally invasive procedures for the treatment of nasal polyps
- Technological advancements in the field of nasal polyps drugs and devices
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Nasal Polyps Drugs Market Research Report
By Type
Corticosteroids, Antibiotics, Leukotriene Inhibitors, Others
By Application
Hospitals, Clinics, Others
By Companies
Pfizer, Roche, Sanofi, Novartis, GlaxoSmithKline, Merck, Regeneron Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
220
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global Nasal Polyps Drugs Market Report Segments:
The global Nasal Polyps Drugs market is segmented on the basis of:
Types
Corticosteroids, Antibiotics, Leukotriene Inhibitors, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Roche
- Sanofi
- Novartis
- GlaxoSmithKline
- Merck
- Regeneron Pharmaceuticals
Highlights of The Nasal Polyps Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Corticosteroids
- Antibiotics
- Leukotriene Inhibitors
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nasal Polyps Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nasal polyps are benign growths on the nasal septum. They can be caused by a variety of factors, including allergies, head and neck cancer, and viral infections. Nasal polyps can cause obstruction of airflow through the nose, which may lead to symptoms such as snoring or difficulty breathing. Treatment typically involves surgically removing the nasal polyp(s).
Some of the key players operating in the nasal polyps drugs market are Pfizer, Roche, Sanofi, Novartis, GlaxoSmithKline, Merck, Regeneron Pharmaceuticals.
The nasal polyps drugs market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nasal Polyps Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Nasal Polyps Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Nasal Polyps Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Nasal Polyps Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Nasal Polyps Drugs Market Size & Forecast, 2018-2028
4.5.1 Nasal Polyps Drugs Market Size and Y-o-Y Growth
4.5.2 Nasal Polyps Drugs Market Absolute $ Opportunity
Chapter 5 Global Nasal Polyps Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Nasal Polyps Drugs Market Size Forecast by Type
5.2.1 Corticosteroids
5.2.2 Antibiotics
5.2.3 Leukotriene Inhibitors
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Nasal Polyps Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Nasal Polyps Drugs Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Nasal Polyps Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Nasal Polyps Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Nasal Polyps Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Nasal Polyps Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Nasal Polyps Drugs Market Size Forecast by Type
9.6.1 Corticosteroids
9.6.2 Antibiotics
9.6.3 Leukotriene Inhibitors
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Nasal Polyps Drugs Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Nasal Polyps Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Nasal Polyps Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Nasal Polyps Drugs Market Size Forecast by Type
10.6.1 Corticosteroids
10.6.2 Antibiotics
10.6.3 Leukotriene Inhibitors
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Nasal Polyps Drugs Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Nasal Polyps Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Nasal Polyps Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Nasal Polyps Drugs Market Size Forecast by Type
11.6.1 Corticosteroids
11.6.2 Antibiotics
11.6.3 Leukotriene Inhibitors
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Nasal Polyps Drugs Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Nasal Polyps Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Nasal Polyps Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Nasal Polyps Drugs Market Size Forecast by Type
12.6.1 Corticosteroids
12.6.2 Antibiotics
12.6.3 Leukotriene Inhibitors
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Nasal Polyps Drugs Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Nasal Polyps Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Nasal Polyps Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Nasal Polyps Drugs Market Size Forecast by Type
13.6.1 Corticosteroids
13.6.2 Antibiotics
13.6.3 Leukotriene Inhibitors
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Nasal Polyps Drugs Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Nasal Polyps Drugs Market: Competitive Dashboard
14.2 Global Nasal Polyps Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Roche
14.3.3 Sanofi
14.3.4 Novartis
14.3.5 GlaxoSmithKline
14.3.6 Merck
14.3.7 Regeneron Pharmaceuticals
